Thomas G Greene

Title: Innovations of Thomas G Greene in Biochemical Detection

Introduction

Thomas G Greene is an accomplished inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemical detection, particularly in the development of methods for identifying specific nucleoside structures in biological specimens. With a total of 2 patents to his name, Greene's work has implications for cancer diagnostics and environmental monitoring.

Latest Patents

Greene's latest patents focus on the detection and quantitation of 8-hydroxyadenine (8-OH-Ade) using monoclonal antibodies. The first patent describes methods and materials for detecting and quantifying 8-OH-Ade in biological specimens. This invention is particularly relevant for diagnosing or monitoring certain types of cancer and other diseases associated with DNA oxidative damage. The monoclonal antibodies developed in this patent are highly specific and can be utilized in various immunoassays. The second patent further enhances the immunoassays for 8-OH-Ade detection, introducing new monoclonal antibodies that improve the accuracy and reliability of these tests.

Career Highlights

Greene is currently associated with Cytochem, Inc., where he continues to innovate in the field of biochemical assays. His work has been instrumental in advancing the understanding of oxidative DNA damage and its implications for health. Greene's research has the potential to impact both clinical diagnostics and environmental health assessments.

Collaborations

Greene collaborates with Eric H Holmes, who is also involved in the research and development of similar biochemical detection methods. Their partnership enhances the scope and effectiveness of their innovations.

Conclusion

Thomas G Greene's contributions to the field of biochemical detection through his patents on 8-OH-Ade are noteworthy. His work not only advances scientific knowledge but also has practical applications in health diagnostics and environmental monitoring.